The START Center for Cancer Care - Midwest — Grand Rapids, Michigan

The START Center for Cancer Care - Midwest is a clinical research site located in Grand Rapids, Michigan, United States 49546.

Crixeo Health Trust Score: 60/100 (FAIR). This profile has not yet been claimed by the site owner.

The START Center for Cancer Care - Midwest has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Lymphoma, Lymphoma, Non Hodgkin, Advanced or Metastatic Solid Tumors.

Sponsors: Treeline Biosciences, Inc., Hanmi Pharmaceutical Company Limited.

Sponsor Feasibility Report

Trust Score: 60/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The START Center for Cancer Care - Midwest?

The START Center for Cancer Care - Midwest has a Crixeo Trust Score of 60/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The START Center for Cancer Care - Midwest conducted?

The START Center for Cancer Care - Midwest has 2 clinical trials on record, with 2 currently active. Their work covers Lymphoma, Lymphoma, Non Hodgkin, Advanced or Metastatic Solid Tumors.

Is The START Center for Cancer Care - Midwest accredited by Crixeo Health?

The START Center for Cancer Care - Midwest has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about The START Center for Cancer Care - Midwest?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.